Aesthetic Plastic Surgery

, Volume 28, Issue 6, pp 441–444 | Cite as

Complications with the Use of Botulinum Toxin Type A in Facial Rejuvenation: Report of 8 Cases

  • Marcus Castro Ferreira
  • Alessandra Grassi Salles
  • Rodrigo Gimenez
  • Maria Fernanda Dematte Soares
Article

Abstract

The botulinum toxin A is produced by Clostridium botulinum and causes a reversible, selective muscle relaxation that leads to a temporary flattening of the mechanical component of wrinkling without the stigmata of invasive surgery. Since the end of the 1980s, this neurotoxin has been used to treat mimic facial lines with good results. Although this is considered a safe therapy, with adverse effects typically self-limited, more severe complications have been observed when it is used by nonskilled physicians or in improper dosages. This article reports eight patients treated with botulinum toxin A for aesthetic purposes who developed different complications. Treatment of the complication included the use of electrical stimulation, lymphatic drainage, antiinflammatory therapy, dipivefrine cloridrate drops, and other approaches. With specific treatment for each patient, the lengths of these complications seemed to be reduced.

Keywords

Aesthetic Botulinum toxin Complications Facial rejuvenation Treatment 

References

  1. 1.
    Ascher, B, Klap, P, Marion, MH,  et al. 1995La toxine botulinique dans le traitement des ritides fronto-glabellaires et de la region orbitaireAnn Chir Plast Esthet406776PubMedGoogle Scholar
  2. 2.
    Carruthers, A, Carruthers, J 1990The treatment of glabellar furrows with botulinum A exotoxinJ Dermatol Surg Oncol1683Google Scholar
  3. 3.
    Carruthers, A, Carruthers, J 1998Clinical indications and injection technique for the cosmetic use of botulinum A exotoxinDermatol Surg2411891194CrossRefPubMedGoogle Scholar
  4. 4.
    Garcia, A, Fulton, E 1996Cosmetic denervation of the muscles of facial expression with botulinum toxinDermatol Surg223943CrossRefPubMedGoogle Scholar
  5. 5.
    Hexsel, D, Mazzuco, R, Zechmeister, M, Hexsel, CL (2002) “Complications and adverse effects: diagnosis and treatment” In: Hexsel, D, Almeida, AT (eds.) “Cosmetic use of botulinum toxin” Age, Portoalegre, Brazil, pp 233–239Google Scholar
  6. 6.
    Keen, M, Kopelman, JE, Aviv, JE, Binder, W, Brin, M, Blitzer, A 1994Botulinum toxin: A novel method to remove periorbital wrinklesFacial Plast Surg10141146PubMedGoogle Scholar
  7. 7.
    Klein, AW, Wexler, P, Carruthers, A, Carruthers, J 1997Treatment of facial furrows and rhytids: Analysis and treatment of the aging faceDermatol Clin15595607PubMedGoogle Scholar
  8. 8.
    Matarasso, SL 1998Complications of botulinum A exotoxin for hyperfunctional linesDermatol Surg2412491254CrossRefPubMedGoogle Scholar
  9. 9.
    Pearce, LB, First, ER, Maccallum, RD, Gupta, A 1997Pharmacologic characterization of botulinum toxin for basic science and medicineToxicon3513731412CrossRefPubMedGoogle Scholar
  10. 10.
    Sommer, B, Sattler, G (eds.) (2001) Botulinum toxin in aesthetic medicine, Blackwell Wissenschafts-Verlag, Berlin – Vienna, pp 1–7Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2004

Authors and Affiliations

  • Marcus Castro Ferreira
    • 1
    • 2
  • Alessandra Grassi Salles
    • 1
  • Rodrigo Gimenez
    • 1
  • Maria Fernanda Dematte Soares
    • 1
  1. 1.Division of Plastic Surgery, Faculty of MedicineUniversity of São PauloSão PauloBrazil
  2. 2.Av. Dr. Arnaldo, 455 – sala 1360São PauloBrazil

Personalised recommendations